MCA stability tool

Check whether tablets and capsules are suitable for a multi-compartment compliance aid (MCA), and build a list to print.

Browse medicines A to Z

A (medicines beginning with A) B (medicines beginning with B) C (medicines beginning with C) D (medicines beginning with D) E (medicines beginning with E) F (medicines beginning with F) G (medicines beginning with G) H (medicines beginning with H) I (medicines beginning with I) K (medicines beginning with K) L (medicines beginning with L) M (medicines beginning with M) N (medicines beginning with N) O (medicines beginning with O) P (medicines beginning with P) Q (medicines beginning with Q) R (medicines beginning with R) S (medicines beginning with S) T (medicines beginning with T) U (medicines beginning with U) V (medicines beginning with V) W (medicines beginning with W) X (medicines beginning with X) Y (medicines beginning with Y) Z (medicines beginning with Z)

Medicines beginning with T

Tranylcypromine

Tranylcypromine 10mg tablets

Use with caution

Stability notes for Tranylcypromine 10mg tablets

Protect from moisture and light. Store in an airtight container.

Provenance

This compatibility recommendation is derived from Tranylcypromine 10mg tablets (Advanz Pharma).

Suppliers (11) of Tranylcypromine 10mg tablets
Tranylcypromine 10mg tablets (A A H Pharmaceuticals Ltd)
Tranylcypromine 10mg tablets (Accord-UK Ltd)
Tranylcypromine 10mg tablets (Advanz Pharma)
Tranylcypromine 10mg tablets (Alliance Healthcare (Distribution) Ltd)
Tranylcypromine 10mg tablets (Aristo Pharma Ltd)
Tranylcypromine 10mg tablets (CST Pharma Ltd)
Tranylcypromine 10mg tablets (Glenmark Pharmaceuticals Europe Ltd)
Tranylcypromine 10mg tablets (Medihealth (Northern) Ltd)
Tranylcypromine 10mg tablets (Necessity Supplies Ltd)
Tranylcypromine 10mg tablets (Pharmaram Ltd)
Tranylcypromine 10mg tablets (Rivopharm (UK) Ltd)

What the ratings mean

Compatible
Suitable for use. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label.
Use with caution
Suitable with mitigations. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label and supported by limited data.
Incompatible
Medicines under this category are not suitable for use in MCAs.
No stability information
These medicines have not been reviewed by SPS.